Inhibition of Key Glycolytic Enzyme Hexokinase 2 Ameliorates Psoriasiform Inflammation in vitro and in vivo
Le Zhuang,1 Weiyuan Ma,2 Jing Jiao1 1Department of Dermatology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, People’s Republic of China; 2Department of Dermatology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, People’s...
Main Authors: | Zhuang L, Ma W, Jiao J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-11-01
|
Series: | Clinical, Cosmetic and Investigational Dermatology |
Subjects: | |
Online Access: | https://www.dovepress.com/inhibition-of-key-glycolytic-enzyme-hexokinase-2-ameliorates-psoriasif-peer-reviewed-fulltext-article-CCID |
Similar Items
-
Inihibition of Glycolysis by Using a Micro/Nano-Lipid Bromopyruvic Chitosan Carrier as a Promising Tool to Improve Treatment of Hepatocellular Carcinoma
by: Nemany A. Hanafy, et al.
Published: (2018-01-01) -
Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model
by: Andrea Cunha, et al.
Published: (2022-09-01) -
Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
by: Tengjiao Fan, et al.
Published: (2019-03-01) -
Hexokinases in cancer and other pathologies
by: Dong Guo, et al.
Published: (2023-02-01) -
Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Mouse Model via Reducing Macrophage Infiltration and Inhibiting Glycolysis
by: Wang Y, et al.
Published: (2023-08-01)